Ayala Pharmaceuticals Company
Ayala Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops targeted cancer therapies for people with genetically defined cancers. The company manufactures gamma secretase inhibitors as targeted treatments for cancers harboring specific notch alterations. The company was founded in 2017 and is based in Rehovot, Israel.
Technology:
Biotechnology, Pharmaceutical
Industry:
Personalized Medicine
Headquarters:
Rehovot, Israel
Founded Date:
2017
Employees Number:
10-50
Funding Status:
Early Stage Venture
Register and Claim Ownership